GSK plc reports

Company location
London
GSK plc has filed 6,818 SEC EDGAR filings since 12 Jan 2001

SEC filing history

Showing 76-100 of 1,000 matching filings.

Per page
25
Current page
4
6-K File 001-15170

RESULT OF AGM

Filing date
06 May 2026
Reporting date
06 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-84251

SCHEDULE 13G filing

Filing date
06 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
05 May 2026
Reporting date
05 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
01 May 2026
Reporting date
01 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

HOLDING(S) IN COMPANY

Filing date
01 May 2026
Reporting date
01 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
29 Apr 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

1ST QUARTER RESULTS

Filing date
29 Apr 2026
Reporting date
29 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
28 Apr 2026
Reporting date
28 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

BEPIROVIRSEN PRIORITY REVIEW US FILING ACCEPTANCE

Filing date
28 Apr 2026
Reporting date
28 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

EFIMOSFERMIN GRANTED US/EU REGULATORY DESIGNATIONS

Filing date
27 Apr 2026
Reporting date
27 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TESARO UPDATE ON ANAPTYSBIO INC. LITIGATION

Filing date
27 Apr 2026
Reporting date
27 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
24 Apr 2026
Reporting date
24 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
23 Apr 2026
Reporting date
23 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
22 Apr 2026
Reporting date
22 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
21 Apr 2026
Reporting date
21 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
20 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

BLENREP APPROVED IN CHINA FOR 2L+ MULTIPLE MYELOMA

Filing date
20 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
20 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
17 Apr 2026
Reporting date
17 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
16 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
16 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK COMPLETES ACQUISITION OF 35PHARMA INC.

Filing date
15 Apr 2026
Reporting date
15 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
15 Apr 2026
Reporting date
15 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Apr 2026
Reporting date
14 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
14 Apr 2026
Reporting date
14 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .